577 related articles for article (PubMed ID: 28509579)
1. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
Phillips L; Basnyat B; Chang Y; Swenson ER; Harris NS
High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure is not associated with acute mountain sickness.
Cushing T; Paterson R; Haukoos J; Harris NS
High Alt Med Biol; 2013 Dec; 14(4):342-5. PubMed ID: 24377341
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Mild Cognitive Impairment with Ascending Altitude.
Algaze I; Phillips L; Inglis P; Lathrop G; Gadbois J; Rizzolo K; Harris NS
High Alt Med Biol; 2020 Jun; 21(2):184-191. PubMed ID: 32282276
[No Abstract] [Full Text] [Related]
4. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
5. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
[No Abstract] [Full Text] [Related]
6. Association between decreased osteopontin and acute mountain sickness upon rapid ascent to 3500 m among young Chinese men.
Tang XG; Wen J; Zhang XS; Jiang DC
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30165389
[TBL] [Abstract][Full Text] [Related]
7. Visual analogue self-assessment of acute mountain sickness in adolescents: experience from two Himalayan expeditions.
Slingo ME; Lowe FS; Pieri AR; Imray CH;
High Alt Med Biol; 2012 Sep; 13(3):185-92. PubMed ID: 22994518
[TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
9. Impact of Sleeping Altitude on Symptoms of Acute Mountain Sickness on Mt. Fuji.
Horiuchi M; Uno T; Endo J; Handa Y; Hasegawa T
High Alt Med Biol; 2018 Jun; 19(2):193-200. PubMed ID: 29741971
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude?
Leichtfried V; Basic D; Burtscher M; Gothe RM; Siebert U; Schobersberger W
Sleep Breath; 2016 Mar; 20(1):435-42. PubMed ID: 26032284
[TBL] [Abstract][Full Text] [Related]
11. Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review.
Meier D; Collet TH; Locatelli I; Cornuz J; Kayser B; Simel DL; Sartori C
JAMA; 2017 Nov; 318(18):1810-1819. PubMed ID: 29136449
[TBL] [Abstract][Full Text] [Related]
12. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro.
Jackson SJ; Varley J; Sellers C; Josephs K; Codrington L; Duke G; Njelekela MA; Drummond G; Sutherland AI; Thompson AA; Baillie JK
High Alt Med Biol; 2010; 11(3):217-22. PubMed ID: 20919888
[TBL] [Abstract][Full Text] [Related]
13. No evidence of intracranial hypertension in trekkers with acute mountain sickness when assessed noninvasively with distortion product otoacoustic emissions.
Olzowy B; Abendroth S; von Gleichenstein G; Mees K; Stelter K
High Alt Med Biol; 2014 Sep; 15(3):364-70. PubMed ID: 25163023
[TBL] [Abstract][Full Text] [Related]
14. Comparison of scoring systems for assessment of acute mountain sickness.
Wagner DR; Teramoto M; Knott JR; Fry JP
High Alt Med Biol; 2012 Dec; 13(4):245-51. PubMed ID: 23270440
[TBL] [Abstract][Full Text] [Related]
15. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
16. Field Ultrasound Evaluation of Central Volume Status and Acute Mountain Sickness.
Pitman JT; Thapa GB; Harris NS
Wilderness Environ Med; 2015 Sep; 26(3):319-26. PubMed ID: 25864086
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Lake Louise Score for Acute Mountain Sickness and Its 2018 Version in a Cohort of 484 Trekkers at High Altitude.
Richalet JP; Julia C; Lhuissier FJ
High Alt Med Biol; 2021 Dec; 22(4):353-361. PubMed ID: 34515528
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetazolamide on cognitive performance during high-altitude exposure.
Wang J; Ke T; Zhang X; Chen Y; Liu M; Chen J; Luo W
Neurotoxicol Teratol; 2013; 35():28-33. PubMed ID: 23280141
[TBL] [Abstract][Full Text] [Related]
19. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
Kayser B; Hulsebosch R; Bosch F
High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
[TBL] [Abstract][Full Text] [Related]
20. Are Pre-Ascent Low-Altitude Saliva Cortisol Levels Related to the Subsequent Acute Mountain Sickness Score? Observations from a Field Study.
Gatterer H; Bernatzky G; Burtscher J; Rainer M; Kayser B; Burtscher M
High Alt Med Biol; 2019 Dec; 20(4):337-343. PubMed ID: 31411495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
